International Journal of Radiation Oncology * Biology * Physics
Volume 72, Issue 1 , Pages 228-235 , 1 September 2008

Risk of Developing Second Cancer From Neutron Dose in Proton Therapy as Function of Field Characteristics, Organ, and Patient Age

  • Christina Zacharatou Jarlskog, Ph.D.

      Affiliations

    • Department of Radiation Oncology, Copenhagen University Hospital, Copenhagen, Denmark
    • ,
  • Harald Paganetti, Ph.D.

      Affiliations

    • Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA
    • Corresponding Author InformationReprint requests to: Harald Paganetti, Ph.D., Department of Radiation Oncology, Massachusetts General Hospital, 30 Fruit St., Boston, MA 02114. Tel: (617) 726-5847; Fax: (617) 724-0368

Received 28 January 2008 ,Revised 23 April 2008 ,Accepted 25 April 2008.

References 

  1. Hall EJ. Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys. 2006;65:1–7
  2. Hall EJ, Wuu C-S. Radiation-induced second cancers: The impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys. 2003;56:83–88
  3. Kry SF, Salehpour M, Followill DS, et al. The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2005;62:1195–1203
  4. Paganetti H, Bortfeld T, Delaney TF. Neutron dose in proton radiation therapy: In regard to Eric J. Hall (Int J Radiat Oncol Biol Phys 2006;65:1–7). Int J Radiat Oncol Biol Phys. 2006;66:1594–1595
  5. Biological Effects of Ionizing Radiation Committee. Health risks from exposure to low levels of ionizing radiation, BEIR VII, Phase 2. Bethesda: National Research Council, National Academy of Science; 2006;
  6. Zacharatou Jarlskog C, Lee C, Bolch WE, et al. Assessment of organ-specific neutron equivalent doses in proton therapy using computational whole-body age-dependent voxel phantoms. Phys Med Biol. 2008;53:693–717
  7. Bassal M, Mertens AC, Taylor L, et al. Risk of selected subsequent carcinomas in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. J Clin Oncol. 2006;24:476–483
  8. Neglia JP, Friedman DL, Yasui Y, et al. Second malignant neoplasms in five-year survivors of childhood cancer: Childhood Cancer Survivor Study. J Natl Cancer Inst. 2001;93:618–629
  9. Tucker MA, Morris Jones PH, Boice JD, et al. Late Effects Study Group Therapeutic radiation at a young age is linked to secondary thyroid cancer. Cancer Res. 1991;51:2885–2888
  10. Palm A, Johansson KA. A review of the impact of photon and proton external beam radiotherapy treatment modalities on the dose distribution in field and out-of-field; Implications for the long-term morbidity of cancer survivors. Acta Oncol. 2007;46:462–473
  11. Miralbell R, Lomax A, Cella L, et al. Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors. Int J Radiat Oncol Biol Phys. 2002;54:824–829
  12. Agosteo S, Birattari C, Caravaggio M, et al. Secondary neutron and photon dose in proton therapy. Radiother Oncol. 1998;48:293–305
  13. Mesoloras G, Sandison GA, Stewart RD, et al. Neutron scattered dose equivalent to a fetus from proton radiotherapy of the mother. Med Phys. 2006;33:2479–2490
  14. Roy SC, Sandison GA. Scattered neutron dose equivalent to a fetus from proton therapy of the mother. Radiat Phys Chem. 2004;71:997–998
  15. Schneider U, Agosteo S, Pedroni E, et al. Secondary neutron dose during proton therapy using spot scanning. Int J Radiat Oncol Biol Phys. 2002;53:244–251
  16. Yan X, Titt U, Koehler AM, et al. Measurement of neutron dose equivalent to proton therapy patients outside of the proton radiation field. Nucl Instrum Methods Phys Res A. 2002;476:429–434
  17. Tayama R, Fujita Y, Tadokoro M, et al. Measurement of neutron dose distribution for a passive scattering nozzle at the Proton Medical Research Center (PMRC). Nucl Instrum Methods Phys Res A. 2006;564:532–536
  18. Wroe A, Rosenfeld A, Schulte R. Out-of-field dose equivalents delivered by proton therapy of prostate cancer. Med Phys. 2007;34:3449–3456
  19. Jiang H, Wang B, Xu XG, et al. Simulation of organ-specific patient effective dose due to secondary neutrons in proton radiation treatment. Phys Med Biol. 2005;50:4337–4353
  20. Polf JC, Newhauser WD. Calculations of neutron dose equivalent exposures from range-modulated proton therapy beams. Phys Med Biol. 2005;50:3859–3873
  21. Zheng Y, Newhauser W, Fontenot J, et al. Monte Carlo study of neutron dose equivalent during passive scattering proton therapy. Phys Med Biol. 2007;52:4481–4496
  22. Klein EE, Maserang B, Wood R, et al. Peripheral doses from pediatric IMRT. Med Phys. 2006;33:2525–2531
  23. Lee C, Lee C, Bolch WE. Age-dependent organ and effective dose coefficients for external photons: A comparison of stylized and voxel-based paediatric phantoms. Phys Med Biol. 2006;51:4663–4688
  24. Xu XG, Chao TC, Bozkurt A. VIP-MAN: An image-based whole-body adult male model constructed from color photographs of the Visible Human Project for multi-particle Monte Carlo calculations. Health Phys. 2000;78:476–486
  25. Lee C, Lee C, Williams JL, et al. Whole-body voxel phantoms of paediatric patients—UF Series B. Phys Med Biol. 2006;51:4649–4661
  26. Lee C, Williams JL, Lee C, et al. The UF series of tomographic computational phantoms of pediatric patients. Med Phys. 2005;32:3537–3548
  27. Paganetti H, Jiang H, Lee S-Y, et al. Accurate Monte Carlo simulations for nozzle design, commissioning and quality assurance for a proton radiation therapy facility. Med Phys. 2004;31:2107–2118
  28. Jiang H, Paganetti H. Adaptation of GEANT4 to Monte Carlo dose calculations based on CT data. Med Phys. 2004;31:2811–2818
  29. International Commission on Radiological Protection . Relative biological effectiveness (RBE), quality factor (Q), and radiation weighting factor (wR). New York: Pergamon Press; 2003;p. 92
  30. National Council on Radiation Protection and Measurements . Limitation of exposure to ionizing radiation (supersedes NCRP Report No. 91): National Council on Radiation Protection and Measurements Report. Bethesda: NRCP; 1993;p. 116
  31. International Commission on Radiological Protection . Recommendations of the International Commission on Radiological Protection. Stockholm: Sweden, International Commission on Radiological Protection (ICRP); 1991;p. 60
  32. Preston DL, Shimizu Y, Pierce DA, et al. Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950–1997. Radiat Res. 2003;160:381–407
  33. Preston DL, Mattsson A, Holmberg E, et al. Radiation effects on breast cancer risk: A pooled analysis of eight cohorts. Radiat Res. 2002;158:220–235
  34. Ron E, Lubin JH, Shore RE, et al. Thyroid cancer after exposure to external radiation: A pooled analysis of seven studies. Radiat Res. 1995;141:259–277
  35. National Institutes of Health NIoH . Report of the NCI-CDC working group to revise the 1985 NIH radioepidemiological tables. Bethesda: NIH Publication; 2003;p. 03-5387
  36. Kellerer AM, Nekolla EA, Walsh L. On the conversion of solid cancer excess relative risk into lifetime attributable risk. Radiat Environ Biophys. 2001;40:249–257
  37. Anderson RN, DeTurk PB. United States life tables, 1999. Hyattsville, MD: National Vital Statistics Reports; 2002;50:1–12
  38. SEER. Cancer Statistics Review 1975–2000. Available from: http://seer.cancer.gov/csr/1975-2000. Accessed March 2007.
  39. Shah AP, Bolch WE, Rajon DA, et al. A paired-image radiation transport model for skeletal dosimetry. J Nucl Med. 2005;46:344–353
  40. Kocher DC, Apostoaei AI, Hoffman FO. Radiation effectiveness factors for use in calculating probability of causation of radiogenic cancers. Health Phys. 2005;89:3–32
  41. National Council on Radiation Protection and Measurements . The relative biological effectiveness of radiations of different quality: National Council on Radiation Protection and Measurements Report. Bethesda: NRCP; 1990;p. 104
  42. Brenner DJ, Hall EJ. Secondary neutrons in clinical proton radiotherapy: A charged issue. Radiother Oncol. 2008;86:165–170
  43. Lee C, Lee C, Staton RJ, et al. Organ and effective doses in pediatric patients undergoing helical multislice computed tomography examination. Med Phys. 2007;34:1858–1873
  44. Brenner DJ, Doll R, Goodhead DT, et al. Cancer risks attributable to low doses of ionizing radiation: Assessing what we really know. Proc Natl Acad Sci USA. 2003;100:13761–13766

 Supported in part by National Cancer Institute Grant R01 CA 116743.

 Conflict of interest: none.

PII: S0360-3016(08)00815-8

doi: 10.1016/j.ijrobp.2008.04.069

International Journal of Radiation Oncology * Biology * Physics
Volume 72, Issue 1 , Pages 228-235 , 1 September 2008

Article Tools

* Image Usage & Resolution